REV-ERB agonist is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-03-06. Numbers and descriptions here follow the published literature rather than marketing material.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, dark | Protect from repeated temperature changes. |
| Common analytical method | LC-MS or HPLC-UV | Reference standard required for comparison. |
| Common synonyms | SR9009; Stenabolic; REV-ERB agonist | Vendor naming may vary. |
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
In addition, Gaboon vipers produce the most painful bite of any venomous snake in the world. A bite causes very rapid and conspicuous swelling, intense pain, severe shock and local blistering. Other symptoms may include uncoordinated movements, defecation, urination, swelling of the tongue and eyelids, convulsions and unconsciousness. Blistering, bruising and necrosis is often very extensive. There may be sudden hypotension, heart damage and dyspnoea. The blood may become incoagulable with internal bleeding that may lead to haematuria and haematemesis. Local tissue damage may require surgical excision and possibly amputation. Healing may be slow and fatalities during the recovery period are not uncommon.
The idea of "no independence before majority rule", commonly abbreviated to "NIBMAR", gained considerable ground in British political circles. When Huggins (who had been recently ennobled as Lord Malvern) asked Britain to make the Federation a dominion in 1956, he was rebuffed. The opposition Dominion Party responded by repeatedly calling for a Federal unilateral declaration of independence (UDI) over the next few years. Following Lord Malvern's retirement in late 1956, his successor Sir Roy Welensky pondered such a move on at least three occasions. Attempting to advance the case for Southern Rhodesian independence, particularly in the event of Federal dissolution, the Southern Rhodesian Prime Minister Sir Edgar Whitehead brokered the 1961 constitution with Britain, which he thought would remove all British powers of reservation over Southern Rhodesian bills and acts, and put the country on the brink of full sovereignty. Despite its containing no independence guarantees, Whitehead, Welensky and other proponents of this constitution presented it to the Southern Rhodesian electorate as the "independence constitution" under which Southern Rhodesia would become a dominion on a par with Australia, Canada and New Zealand if the Federation dissolved. White dissenters included Ian Smith, MP for Gwanda and Chief Whip for the governing United Federal Party (UFP) in the Federal Assembly, who took exception to the constitution's omission of an explicit promise of Southern Rhodesian independence in the event of Federal dissolution, and ultimately resigned his post in protest.
== History == SJS is named for Albert Mason Stevens and Frank Chambliss Johnson, American pediatricians who jointly published a description of the disorder in the American Journal of Diseases of Children in 1922.
The Kingdom of Kucha, the most populous oasis in the Tarim Basin, occupied a strategic position on the Northern Silk Road, which brought it prosperity, and made it a wealthy center of trade and culture. Kucha was part of the Silk Road economy, and was in contact with the rest of Central Asia, including Sogdiana and Bactria, and thus also with the cultures of India, Iran, and coastal areas of China. Early visitors are known, such as Maes Titianus. Since the 2nd century CE, under the auspices of the Han dynasty and the Kushan Empire, numerous great Buddhist missionaries passed through the Tarim Basin on their way to China, such as the Parthian An Shigao, the Yuezhis Lokaksema and Zhi Qian, or the Indian Chu Sho-fu (竺朔佛). Culture flourished, and Indian Sanskrit scriptures were being translated by the Kuchean monk and translator Kumarajiva (344–413 CE), himself the son of a Buddhist man from Kashmir and a Kuchean princess, sister of the King. The 1st Style, sometimes called "First Indo-Iranian style" to denote influences from India and Central Asia, covers a period from 300 to 500 CE, and is characterized by Gandharan themes and orange and green hues, having a strong flavour of India: female dancers and musicians are often naked or half-naked with full breasts. The art of these paintings is quite refined, and forms the "Classical" period of the art of Kizil: the shades are delicate, the lines are fine and elegant, the colors blend progressively to give a sense of texture and volume.
Sources: en.wikipedia.org
Greater emphasis on risk management Introduces “Special Requirements” Introduces “Critical Items” Measure: Requirements conformance Measure: Delivery performance Adopt proven product development processes Eliminate “recurring corrective actions” AS9100 Revision C was released in January, 2009, with considerable delay in application of the new version in audits, largely due to the delay in the release of AS9101 Revision D and auditor training to the increased auditing rigor of that update. AS9100 Revision D (2016), Quality Management System – Requirements for Aviation, Space and Defense Organizations The update of AS9100 from revision C to D includes the full text of ISO 9001:2015. In addition to aligning the structure of the aviation, space and defense requirements to the new structure of ISO 9001:2015, the following key changes were implemented:
==== Example: half-life of Rb-87 ==== One gram of rubidium-87 and a radioactivity count rate that, after taking solid angle effects into account, is consistent with a decay rate of 3200 decays per second corresponds to a specific activity of 3.2×106 Bq/kg. Rubidium atomic mass is 87 g mol−1, so one gram is 1/87 of a mole. Plugging in the numbers:
== Medical uses == Ertugliflozin is indicated for the treatment of adults with insufficiently controlled type 2 diabetes as an adjunct to diet and exercise as monotherapy when metformin is considered inappropriate due to intolerance or contraindications or in addition to other medicinal products for the treatment of diabetes. A systematic review and meta-analysis of ertugliflozin, published in 2024, found it to have a good glycemic efficacy and a reassuring safety profile in managing type 2 diabetes.
Sources: en.wikipedia.org
== Secretion and Regulation == Release of little gastrin I is triggered by the presence of proteins and amino acids in the stomach, gastric distension as well as elevated stomach pH. The release is also promoted by vagal nerve stimulation. Secretion is inhibited by Somatostatin and by acidic gastric pH. This forms a negative feedback loop. Its half-life in circulation is short, around 3-7 minutes, after which it is mainly broken down by the kidneys .
The figure shows the main components of an APPI source: a nebulizer probe which can be heated to 350–500 °C, an ionization region with a VUV photon source, and an ion-transfer region under intermediate pressure that introduces ions into the MS analyzer. The analyte(s) in solution from the HPLC flows into the nebulizer at a flow rate that can range from μL/min to mL/min range. The liquid flow is vaporized by nebulization and heat. The vaporized sample then enters into the radiation zone of the VUV source. Sample ions then enter into the MS interface region, frequently a capillary through the combination of a decreasing pressure gradient and electric fields. APPI has been commercially developed as dual ionization sources more commonly with APCI, but also with ESI.
=== Sales === The Valve Index headset, controllers, and base stations sold out in the US, Canada, and Europe within a week of the Alyx announcement. By mid-January 2020, they were sold out in all 31 regions. According to Superdata, Valve sold 103,000 Index units in the fourth quarter of 2019 as a result of the Alyx announcements, compared to the total 149,000 sold throughout 2019, and the Index was the highest-selling VR headset for PCs during that quarter. Though Valve had expected to supply several Index orders in time for the release of Alyx, the COVID-19 pandemic limited their supply chain. Valve's Greg Coomer said Valve knew many people would not play Alyx on launch and that its audience was "relatively small right now". Newell described it as a "forward investment" into long-term technologies. In 2021, PCGamesN wrote that though it was "artfully crafted", Alyx had had little cultural impact. As of December 2024, Alyx had sold more than two million copies.
Sources: en.wikipedia.org
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.
The solid is usually kept desiccated at -20 °C or lower and protected from light. Stock solutions are aliquoted to limit freeze–thaw cycles. Aqueous solutions are not generally recommended for long-term storage.
Laws differ by country and by intended use. It is not an approved medicine, and many vendors sell it as a research chemical. Purchasers are responsible for confirming local restrictions.
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.